FDA Succession Planning Targeted In Congress As Hamburg Heads For Exit
This article was originally published in The Gray Sheet
Executive Summary
Margaret Hamburg’s departure from commissioner post seems to be proceeding smoothly; proposals in the House 21st Century Cures discussion draft would mandate a similar process always be followed.